China Bio-Immunity Corporation
Lixin Zhou, c/o Frascona, Joiner, Goodman and Greenstein, P.C.
4750 Table Mesa Drive
Boulder, Colorado 80305.
November 24, 2009
John Krug
Senior Counsel
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E. Mail Stop 4720
Washington, D.C. 20549
Re:
China Bio-Immunity Corporation.
Preliminary information statement filed October 20, 2009
File No. 000-51760
Dear Mr. Krug:
In connection with responding to your comment letter dated October 22, 2009, China Bio-Immunity Corporation, a Nevada corporation (the “Company”), hereby acknowledges that:
·
the Company is responsible for the adequacy and accuracy of the disclosure in the filing;
·
staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and
·
the Company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Sincerely yours,
China Bio-Immunity Corporation
/s/ Lixin Zhou, Interim Chief Executive Officer
